nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Etoposide—brain cancer	0.468	1	CbGbCtD
Raltegravir—CCR1—pituitary gland—brain cancer	0.0104	0.147	CbGeAlD
Raltegravir—CCR1—medulla oblongata—brain cancer	0.0101	0.142	CbGeAlD
Raltegravir—CCR1—midbrain—brain cancer	0.00919	0.129	CbGeAlD
Raltegravir—CCR1—spinal cord—brain cancer	0.00896	0.126	CbGeAlD
Raltegravir—CCR1—endocrine gland—brain cancer	0.00807	0.114	CbGeAlD
Raltegravir—CCR1—head—brain cancer	0.00797	0.112	CbGeAlD
Raltegravir—CCR1—central nervous system—brain cancer	0.00727	0.102	CbGeAlD
Raltegravir—CCR1—brain—brain cancer	0.00577	0.0813	CbGeAlD
Raltegravir—UGT1A1—endocrine gland—brain cancer	0.00332	0.0467	CbGeAlD
Raltegravir—Myalgia—Procarbazine—brain cancer	0.00127	0.00284	CcSEcCtD
Raltegravir—Anxiety—Procarbazine—brain cancer	0.00126	0.00283	CcSEcCtD
Raltegravir—Neutropenia—Carmustine—brain cancer	0.00125	0.0028	CcSEcCtD
Raltegravir—Bronchitis—Temozolomide—brain cancer	0.00124	0.00278	CcSEcCtD
Raltegravir—Dry mouth—Procarbazine—brain cancer	0.00124	0.00277	CcSEcCtD
Raltegravir—Confusional state—Procarbazine—brain cancer	0.00122	0.00274	CcSEcCtD
Raltegravir—Vomiting—Lomustine—brain cancer	0.00122	0.00272	CcSEcCtD
Raltegravir—Neutropenia—Temozolomide—brain cancer	0.00121	0.0027	CcSEcCtD
Raltegravir—Infection—Procarbazine—brain cancer	0.00121	0.0027	CcSEcCtD
Raltegravir—Hyperglycaemia—Carmustine—brain cancer	0.0012	0.0027	CcSEcCtD
Raltegravir—Angiopathy—Hydroxyurea—brain cancer	0.0012	0.00269	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Temozolomide—brain cancer	0.0012	0.00269	CcSEcCtD
Raltegravir—Erectile dysfunction—Temozolomide—brain cancer	0.00119	0.00266	CcSEcCtD
Raltegravir—Thrombocytopenia—Procarbazine—brain cancer	0.00119	0.00266	CcSEcCtD
Raltegravir—Depression—Carmustine—brain cancer	0.00119	0.00266	CcSEcCtD
Raltegravir—Chills—Hydroxyurea—brain cancer	0.00119	0.00266	CcSEcCtD
Raltegravir—Weight increased—Temozolomide—brain cancer	0.00117	0.00263	CcSEcCtD
Raltegravir—Hyperhidrosis—Procarbazine—brain cancer	0.00117	0.00263	CcSEcCtD
Raltegravir—Renal failure—Carmustine—brain cancer	0.00117	0.00262	CcSEcCtD
Raltegravir—Alopecia—Hydroxyurea—brain cancer	0.00117	0.00262	CcSEcCtD
Raltegravir—Weight decreased—Temozolomide—brain cancer	0.00117	0.00262	CcSEcCtD
Raltegravir—Neuropathy peripheral—Carmustine—brain cancer	0.00117	0.00261	CcSEcCtD
Raltegravir—Hyperglycaemia—Temozolomide—brain cancer	0.00116	0.00261	CcSEcCtD
Raltegravir—Erythema—Hydroxyurea—brain cancer	0.00115	0.00258	CcSEcCtD
Raltegravir—Infestation—Temozolomide—brain cancer	0.00115	0.00258	CcSEcCtD
Raltegravir—Infestation NOS—Temozolomide—brain cancer	0.00115	0.00258	CcSEcCtD
Raltegravir—Depression—Temozolomide—brain cancer	0.00115	0.00257	CcSEcCtD
Raltegravir—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00115	0.0798	CbGpPWpGaD
Raltegravir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00114	0.00256	CcSEcCtD
Raltegravir—Nausea—Lomustine—brain cancer	0.00114	0.00254	CcSEcCtD
Raltegravir—Neuropathy peripheral—Temozolomide—brain cancer	0.00113	0.00253	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00111	0.00248	CcSEcCtD
Raltegravir—Insomnia—Procarbazine—brain cancer	0.0011	0.00246	CcSEcCtD
Raltegravir—Paraesthesia—Procarbazine—brain cancer	0.00109	0.00244	CcSEcCtD
Raltegravir—Hepatobiliary disease—Temozolomide—brain cancer	0.00109	0.00244	CcSEcCtD
Raltegravir—Somnolence—Procarbazine—brain cancer	0.00108	0.00242	CcSEcCtD
Raltegravir—Ill-defined disorder—Hydroxyurea—brain cancer	0.00107	0.00239	CcSEcCtD
Raltegravir—Anaemia—Hydroxyurea—brain cancer	0.00106	0.00238	CcSEcCtD
Raltegravir—Hallucination—Carmustine—brain cancer	0.00106	0.00238	CcSEcCtD
Raltegravir—Hypoaesthesia—Carmustine—brain cancer	0.00106	0.00238	CcSEcCtD
Raltegravir—Decreased appetite—Procarbazine—brain cancer	0.00105	0.00236	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Etoposide—brain cancer	0.00105	0.00236	CcSEcCtD
Raltegravir—Oedema peripheral—Carmustine—brain cancer	0.00105	0.00236	CcSEcCtD
Raltegravir—Connective tissue disorder—Carmustine—brain cancer	0.00105	0.00235	CcSEcCtD
Raltegravir—Fatigue—Procarbazine—brain cancer	0.00105	0.00234	CcSEcCtD
Raltegravir—Malaise—Hydroxyurea—brain cancer	0.00104	0.00232	CcSEcCtD
Raltegravir—Pain—Procarbazine—brain cancer	0.00104	0.00232	CcSEcCtD
Raltegravir—Constipation—Procarbazine—brain cancer	0.00104	0.00232	CcSEcCtD
Raltegravir—Hepatitis—Temozolomide—brain cancer	0.00103	0.00231	CcSEcCtD
Raltegravir—Visual impairment—Carmustine—brain cancer	0.00103	0.00231	CcSEcCtD
Raltegravir—Hypoaesthesia—Temozolomide—brain cancer	0.00103	0.0023	CcSEcCtD
Raltegravir—Hallucination—Temozolomide—brain cancer	0.00103	0.0023	CcSEcCtD
Raltegravir—Urinary tract disorder—Temozolomide—brain cancer	0.00102	0.00228	CcSEcCtD
Raltegravir—Oedema peripheral—Temozolomide—brain cancer	0.00102	0.00228	CcSEcCtD
Raltegravir—Connective tissue disorder—Temozolomide—brain cancer	0.00101	0.00227	CcSEcCtD
Raltegravir—Urethral disorder—Temozolomide—brain cancer	0.00101	0.00227	CcSEcCtD
Raltegravir—Feeling abnormal—Procarbazine—brain cancer	0.001	0.00224	CcSEcCtD
Raltegravir—Eye disorder—Carmustine—brain cancer	0.000999	0.00224	CcSEcCtD
Raltegravir—Visual impairment—Temozolomide—brain cancer	0.000995	0.00223	CcSEcCtD
Raltegravir—Gastrointestinal pain—Procarbazine—brain cancer	0.000992	0.00222	CcSEcCtD
Raltegravir—Erythema multiforme—Temozolomide—brain cancer	0.000976	0.00219	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000973	0.00218	CcSEcCtD
Raltegravir—Discomfort—Hydroxyurea—brain cancer	0.000968	0.00217	CcSEcCtD
Raltegravir—Neutropenia—Etoposide—brain cancer	0.000965	0.00216	CcSEcCtD
Raltegravir—Eye disorder—Temozolomide—brain cancer	0.000965	0.00216	CcSEcCtD
Raltegravir—Urticaria—Procarbazine—brain cancer	0.000964	0.00216	CcSEcCtD
Raltegravir—Tinnitus—Temozolomide—brain cancer	0.000963	0.00216	CcSEcCtD
Raltegravir—Abdominal pain—Procarbazine—brain cancer	0.000959	0.00215	CcSEcCtD
Raltegravir—Body temperature increased—Procarbazine—brain cancer	0.000959	0.00215	CcSEcCtD
Raltegravir—Cardiac disorder—Temozolomide—brain cancer	0.000958	0.00215	CcSEcCtD
Raltegravir—Alopecia—Carmustine—brain cancer	0.000944	0.00212	CcSEcCtD
Raltegravir—Angiopathy—Temozolomide—brain cancer	0.000937	0.0021	CcSEcCtD
Raltegravir—Mental disorder—Carmustine—brain cancer	0.000936	0.0021	CcSEcCtD
Raltegravir—Infection—Hydroxyurea—brain cancer	0.000933	0.00209	CcSEcCtD
Raltegravir—Immune system disorder—Temozolomide—brain cancer	0.000933	0.00209	CcSEcCtD
Raltegravir—Mediastinal disorder—Temozolomide—brain cancer	0.000931	0.00209	CcSEcCtD
Raltegravir—Malnutrition—Carmustine—brain cancer	0.00093	0.00208	CcSEcCtD
Raltegravir—Erythema—Carmustine—brain cancer	0.00093	0.00208	CcSEcCtD
Raltegravir—Chills—Temozolomide—brain cancer	0.000926	0.00208	CcSEcCtD
Raltegravir—Nervous system disorder—Hydroxyurea—brain cancer	0.000921	0.00206	CcSEcCtD
Raltegravir—Infestation—Etoposide—brain cancer	0.00092	0.00206	CcSEcCtD
Raltegravir—Infestation NOS—Etoposide—brain cancer	0.00092	0.00206	CcSEcCtD
Raltegravir—Thrombocytopenia—Hydroxyurea—brain cancer	0.000919	0.00206	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000912	0.00204	CcSEcCtD
Raltegravir—Alopecia—Temozolomide—brain cancer	0.000912	0.00204	CcSEcCtD
Raltegravir—Skin disorder—Hydroxyurea—brain cancer	0.000912	0.00204	CcSEcCtD
Raltegravir—Acute coronary syndrome—Etoposide—brain cancer	0.000907	0.00203	CcSEcCtD
Raltegravir—Renal failure—Etoposide—brain cancer	0.000905	0.00203	CcSEcCtD
Raltegravir—Mental disorder—Temozolomide—brain cancer	0.000905	0.00203	CcSEcCtD
Raltegravir—Neuropathy peripheral—Etoposide—brain cancer	0.000902	0.00202	CcSEcCtD
Raltegravir—Myocardial infarction—Etoposide—brain cancer	0.000902	0.00202	CcSEcCtD
Raltegravir—Back pain—Carmustine—brain cancer	0.0009	0.00202	CcSEcCtD
Raltegravir—Erythema—Temozolomide—brain cancer	0.000899	0.00201	CcSEcCtD
Raltegravir—Malnutrition—Temozolomide—brain cancer	0.000899	0.00201	CcSEcCtD
Raltegravir—Hypersensitivity—Procarbazine—brain cancer	0.000894	0.002	CcSEcCtD
Raltegravir—Dysgeusia—Temozolomide—brain cancer	0.00088	0.00197	CcSEcCtD
Raltegravir—Tremor—Carmustine—brain cancer	0.000871	0.00195	CcSEcCtD
Raltegravir—Asthenia—Procarbazine—brain cancer	0.000871	0.00195	CcSEcCtD
Raltegravir—Hepatobiliary disease—Etoposide—brain cancer	0.00087	0.00195	CcSEcCtD
Raltegravir—Back pain—Temozolomide—brain cancer	0.000869	0.00195	CcSEcCtD
Raltegravir—Anaemia—Carmustine—brain cancer	0.00086	0.00193	CcSEcCtD
Raltegravir—Pruritus—Procarbazine—brain cancer	0.000858	0.00192	CcSEcCtD
Raltegravir—Agitation—Carmustine—brain cancer	0.000855	0.00192	CcSEcCtD
Raltegravir—Tremor—Temozolomide—brain cancer	0.000842	0.00189	CcSEcCtD
Raltegravir—Somnolence—Hydroxyurea—brain cancer	0.000835	0.00187	CcSEcCtD
Raltegravir—Ill-defined disorder—Temozolomide—brain cancer	0.000834	0.00187	CcSEcCtD
Raltegravir—Anaemia—Temozolomide—brain cancer	0.000831	0.00186	CcSEcCtD
Raltegravir—Diarrhoea—Procarbazine—brain cancer	0.00083	0.00186	CcSEcCtD
Raltegravir—Dyspepsia—Hydroxyurea—brain cancer	0.000827	0.00185	CcSEcCtD
Raltegravir—Agitation—Temozolomide—brain cancer	0.000826	0.00185	CcSEcCtD
Raltegravir—Hypoaesthesia—Etoposide—brain cancer	0.000822	0.00184	CcSEcCtD
Raltegravir—Decreased appetite—Hydroxyurea—brain cancer	0.000816	0.00183	CcSEcCtD
Raltegravir—Urinary tract disorder—Etoposide—brain cancer	0.000816	0.00183	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000811	0.00182	CcSEcCtD
Raltegravir—Malaise—Temozolomide—brain cancer	0.000811	0.00182	CcSEcCtD
Raltegravir—Urethral disorder—Etoposide—brain cancer	0.00081	0.00181	CcSEcCtD
Raltegravir—Fatigue—Hydroxyurea—brain cancer	0.00081	0.00181	CcSEcCtD
Raltegravir—Vertigo—Temozolomide—brain cancer	0.000808	0.00181	CcSEcCtD
Raltegravir—Hypertension—Carmustine—brain cancer	0.000803	0.0018	CcSEcCtD
Raltegravir—Constipation—Hydroxyurea—brain cancer	0.000803	0.0018	CcSEcCtD
Raltegravir—Pain—Hydroxyurea—brain cancer	0.000803	0.0018	CcSEcCtD
Raltegravir—Dizziness—Procarbazine—brain cancer	0.000802	0.0018	CcSEcCtD
Raltegravir—Palpitations—Temozolomide—brain cancer	0.000794	0.00178	CcSEcCtD
Raltegravir—Chest pain—Carmustine—brain cancer	0.000792	0.00177	CcSEcCtD
Raltegravir—Myalgia—Carmustine—brain cancer	0.000792	0.00177	CcSEcCtD
Raltegravir—Anxiety—Carmustine—brain cancer	0.000789	0.00177	CcSEcCtD
Raltegravir—Cough—Temozolomide—brain cancer	0.000784	0.00176	CcSEcCtD
Raltegravir—Erythema multiforme—Etoposide—brain cancer	0.000781	0.00175	CcSEcCtD
Raltegravir—Hypertension—Temozolomide—brain cancer	0.000776	0.00174	CcSEcCtD
Raltegravir—Feeling abnormal—Hydroxyurea—brain cancer	0.000774	0.00173	CcSEcCtD
Raltegravir—Eye disorder—Etoposide—brain cancer	0.000772	0.00173	CcSEcCtD
Raltegravir—Vomiting—Procarbazine—brain cancer	0.000771	0.00173	CcSEcCtD
Raltegravir—Cardiac disorder—Etoposide—brain cancer	0.000767	0.00172	CcSEcCtD
Raltegravir—Confusional state—Carmustine—brain cancer	0.000765	0.00172	CcSEcCtD
Raltegravir—Myalgia—Temozolomide—brain cancer	0.000765	0.00171	CcSEcCtD
Raltegravir—Arthralgia—Temozolomide—brain cancer	0.000765	0.00171	CcSEcCtD
Raltegravir—Rash—Procarbazine—brain cancer	0.000765	0.00171	CcSEcCtD
Raltegravir—Dermatitis—Procarbazine—brain cancer	0.000764	0.00171	CcSEcCtD
Raltegravir—Anxiety—Temozolomide—brain cancer	0.000763	0.00171	CcSEcCtD
Raltegravir—Headache—Procarbazine—brain cancer	0.00076	0.0017	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00076	0.0017	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—PTCH2—brain cancer	0.000757	0.0528	CbGpPWpGaD
Raltegravir—Discomfort—Temozolomide—brain cancer	0.000756	0.00169	CcSEcCtD
Raltegravir—Infection—Carmustine—brain cancer	0.000754	0.00169	CcSEcCtD
Raltegravir—Angiopathy—Etoposide—brain cancer	0.00075	0.00168	CcSEcCtD
Raltegravir—Dry mouth—Temozolomide—brain cancer	0.000748	0.00168	CcSEcCtD
Raltegravir—Immune system disorder—Etoposide—brain cancer	0.000746	0.00167	CcSEcCtD
Raltegravir—Mediastinal disorder—Etoposide—brain cancer	0.000745	0.00167	CcSEcCtD
Raltegravir—Thrombocytopenia—Carmustine—brain cancer	0.000743	0.00167	CcSEcCtD
Raltegravir—Body temperature increased—Hydroxyurea—brain cancer	0.000742	0.00166	CcSEcCtD
Raltegravir—Chills—Etoposide—brain cancer	0.000741	0.00166	CcSEcCtD
Raltegravir—Confusional state—Temozolomide—brain cancer	0.00074	0.00166	CcSEcCtD
Raltegravir—Alopecia—Etoposide—brain cancer	0.00073	0.00164	CcSEcCtD
Raltegravir—Infection—Temozolomide—brain cancer	0.000729	0.00163	CcSEcCtD
Raltegravir—Nausea—Procarbazine—brain cancer	0.000721	0.00161	CcSEcCtD
Raltegravir—Nervous system disorder—Temozolomide—brain cancer	0.000719	0.00161	CcSEcCtD
Raltegravir—Thrombocytopenia—Temozolomide—brain cancer	0.000718	0.00161	CcSEcCtD
Raltegravir—Skin disorder—Temozolomide—brain cancer	0.000713	0.0016	CcSEcCtD
Raltegravir—Hyperhidrosis—Temozolomide—brain cancer	0.000709	0.00159	CcSEcCtD
Raltegravir—Dysgeusia—Etoposide—brain cancer	0.000704	0.00158	CcSEcCtD
Raltegravir—Back pain—Etoposide—brain cancer	0.000696	0.00156	CcSEcCtD
Raltegravir—Hypersensitivity—Hydroxyurea—brain cancer	0.000692	0.00155	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Carmustine—brain cancer	0.000692	0.00155	CcSEcCtD
Raltegravir—Insomnia—Carmustine—brain cancer	0.000687	0.00154	CcSEcCtD
Raltegravir—Paraesthesia—Carmustine—brain cancer	0.000682	0.00153	CcSEcCtD
Raltegravir—Somnolence—Carmustine—brain cancer	0.000675	0.00151	CcSEcCtD
Raltegravir—Asthenia—Hydroxyurea—brain cancer	0.000674	0.00151	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000668	0.0015	CcSEcCtD
Raltegravir—Ill-defined disorder—Etoposide—brain cancer	0.000667	0.0015	CcSEcCtD
Raltegravir—Anaemia—Etoposide—brain cancer	0.000665	0.00149	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—OR4C12—brain cancer	0.000664	0.0463	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—OR14C36—brain cancer	0.000664	0.0463	CbGpPWpGaD
Raltegravir—Insomnia—Temozolomide—brain cancer	0.000663	0.00149	CcSEcCtD
Raltegravir—Decreased appetite—Carmustine—brain cancer	0.00066	0.00148	CcSEcCtD
Raltegravir—Paraesthesia—Temozolomide—brain cancer	0.000659	0.00148	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Carmustine—brain cancer	0.000655	0.00147	CcSEcCtD
Raltegravir—Somnolence—Temozolomide—brain cancer	0.000652	0.00146	CcSEcCtD
Raltegravir—Pain—Carmustine—brain cancer	0.000649	0.00145	CcSEcCtD
Raltegravir—Constipation—Carmustine—brain cancer	0.000649	0.00145	CcSEcCtD
Raltegravir—Malaise—Etoposide—brain cancer	0.000649	0.00145	CcSEcCtD
Raltegravir—Vertigo—Etoposide—brain cancer	0.000646	0.00145	CcSEcCtD
Raltegravir—Dyspepsia—Temozolomide—brain cancer	0.000646	0.00145	CcSEcCtD
Raltegravir—Diarrhoea—Hydroxyurea—brain cancer	0.000642	0.00144	CcSEcCtD
Raltegravir—Decreased appetite—Temozolomide—brain cancer	0.000638	0.00143	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000633	0.00142	CcSEcCtD
Raltegravir—Fatigue—Temozolomide—brain cancer	0.000632	0.00142	CcSEcCtD
Raltegravir—Cough—Etoposide—brain cancer	0.000628	0.00141	CcSEcCtD
Raltegravir—Constipation—Temozolomide—brain cancer	0.000627	0.00141	CcSEcCtD
Raltegravir—Pain—Temozolomide—brain cancer	0.000627	0.00141	CcSEcCtD
Raltegravir—Feeling abnormal—Carmustine—brain cancer	0.000626	0.0014	CcSEcCtD
Raltegravir—Hypertension—Etoposide—brain cancer	0.000621	0.00139	CcSEcCtD
Raltegravir—Dizziness—Hydroxyurea—brain cancer	0.000621	0.00139	CcSEcCtD
Raltegravir—Gastrointestinal pain—Carmustine—brain cancer	0.000621	0.00139	CcSEcCtD
Raltegravir—Chest pain—Etoposide—brain cancer	0.000612	0.00137	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000608	0.00136	CcSEcCtD
Raltegravir—Discomfort—Etoposide—brain cancer	0.000605	0.00136	CcSEcCtD
Raltegravir—Feeling abnormal—Temozolomide—brain cancer	0.000605	0.00135	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—OR14C36—brain cancer	0.000603	0.042	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—OR4C12—brain cancer	0.000603	0.042	CbGpPWpGaD
Raltegravir—Body temperature increased—Carmustine—brain cancer	0.0006	0.00134	CcSEcCtD
Raltegravir—Abdominal pain—Carmustine—brain cancer	0.0006	0.00134	CcSEcCtD
Raltegravir—Gastrointestinal pain—Temozolomide—brain cancer	0.0006	0.00134	CcSEcCtD
Raltegravir—Vomiting—Hydroxyurea—brain cancer	0.000597	0.00134	CcSEcCtD
Raltegravir—Rash—Hydroxyurea—brain cancer	0.000592	0.00133	CcSEcCtD
Raltegravir—Confusional state—Etoposide—brain cancer	0.000592	0.00133	CcSEcCtD
Raltegravir—Dermatitis—Hydroxyurea—brain cancer	0.000592	0.00133	CcSEcCtD
Raltegravir—UGT1A1—Irinotecan Pathway—APC—brain cancer	0.000588	0.041	CbGpPWpGaD
Raltegravir—Headache—Hydroxyurea—brain cancer	0.000588	0.00132	CcSEcCtD
Raltegravir—Infection—Etoposide—brain cancer	0.000583	0.00131	CcSEcCtD
Raltegravir—Urticaria—Temozolomide—brain cancer	0.000583	0.00131	CcSEcCtD
Raltegravir—Body temperature increased—Temozolomide—brain cancer	0.00058	0.0013	CcSEcCtD
Raltegravir—Abdominal pain—Temozolomide—brain cancer	0.00058	0.0013	CcSEcCtD
Raltegravir—Thrombocytopenia—Etoposide—brain cancer	0.000575	0.00129	CcSEcCtD
Raltegravir—Skin disorder—Etoposide—brain cancer	0.00057	0.00128	CcSEcCtD
Raltegravir—Hyperhidrosis—Etoposide—brain cancer	0.000567	0.00127	CcSEcCtD
Raltegravir—Hypersensitivity—Carmustine—brain cancer	0.000559	0.00125	CcSEcCtD
Raltegravir—Nausea—Hydroxyurea—brain cancer	0.000558	0.00125	CcSEcCtD
Raltegravir—Asthenia—Carmustine—brain cancer	0.000545	0.00122	CcSEcCtD
Raltegravir—Hypersensitivity—Temozolomide—brain cancer	0.00054	0.00121	CcSEcCtD
Raltegravir—Paraesthesia—Etoposide—brain cancer	0.000527	0.00118	CcSEcCtD
Raltegravir—Asthenia—Temozolomide—brain cancer	0.000526	0.00118	CcSEcCtD
Raltegravir—Somnolence—Etoposide—brain cancer	0.000522	0.00117	CcSEcCtD
Raltegravir—Diarrhoea—Carmustine—brain cancer	0.000519	0.00116	CcSEcCtD
Raltegravir—Pruritus—Temozolomide—brain cancer	0.000519	0.00116	CcSEcCtD
Raltegravir—Decreased appetite—Etoposide—brain cancer	0.00051	0.00114	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Etoposide—brain cancer	0.000507	0.00114	CcSEcCtD
Raltegravir—Fatigue—Etoposide—brain cancer	0.000506	0.00113	CcSEcCtD
Raltegravir—Dizziness—Carmustine—brain cancer	0.000502	0.00112	CcSEcCtD
Raltegravir—Constipation—Etoposide—brain cancer	0.000502	0.00112	CcSEcCtD
Raltegravir—Pain—Etoposide—brain cancer	0.000502	0.00112	CcSEcCtD
Raltegravir—Diarrhoea—Temozolomide—brain cancer	0.000502	0.00112	CcSEcCtD
Raltegravir—Dizziness—Temozolomide—brain cancer	0.000485	0.00109	CcSEcCtD
Raltegravir—Feeling abnormal—Etoposide—brain cancer	0.000484	0.00108	CcSEcCtD
Raltegravir—Vomiting—Carmustine—brain cancer	0.000483	0.00108	CcSEcCtD
Raltegravir—Gastrointestinal pain—Etoposide—brain cancer	0.00048	0.00108	CcSEcCtD
Raltegravir—Rash—Carmustine—brain cancer	0.000479	0.00107	CcSEcCtD
Raltegravir—Dermatitis—Carmustine—brain cancer	0.000478	0.00107	CcSEcCtD
Raltegravir—Headache—Carmustine—brain cancer	0.000476	0.00107	CcSEcCtD
Raltegravir—Vomiting—Temozolomide—brain cancer	0.000466	0.00105	CcSEcCtD
Raltegravir—Urticaria—Etoposide—brain cancer	0.000466	0.00104	CcSEcCtD
Raltegravir—Abdominal pain—Etoposide—brain cancer	0.000464	0.00104	CcSEcCtD
Raltegravir—Body temperature increased—Etoposide—brain cancer	0.000464	0.00104	CcSEcCtD
Raltegravir—Rash—Temozolomide—brain cancer	0.000463	0.00104	CcSEcCtD
Raltegravir—Dermatitis—Temozolomide—brain cancer	0.000462	0.00104	CcSEcCtD
Raltegravir—Headache—Temozolomide—brain cancer	0.00046	0.00103	CcSEcCtD
Raltegravir—Nausea—Carmustine—brain cancer	0.000451	0.00101	CcSEcCtD
Raltegravir—Nausea—Temozolomide—brain cancer	0.000436	0.000976	CcSEcCtD
Raltegravir—Hypersensitivity—Etoposide—brain cancer	0.000432	0.000969	CcSEcCtD
Raltegravir—Asthenia—Etoposide—brain cancer	0.000421	0.000944	CcSEcCtD
Raltegravir—Pruritus—Etoposide—brain cancer	0.000415	0.000931	CcSEcCtD
Raltegravir—Diarrhoea—Etoposide—brain cancer	0.000402	0.0009	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—SHH—brain cancer	0.00039	0.0272	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PTCH2—brain cancer	0.000389	0.0271	CbGpPWpGaD
Raltegravir—Dizziness—Etoposide—brain cancer	0.000388	0.00087	CcSEcCtD
Raltegravir—Vomiting—Etoposide—brain cancer	0.000373	0.000836	CcSEcCtD
Raltegravir—Rash—Etoposide—brain cancer	0.00037	0.000829	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—PTCH1—brain cancer	0.00037	0.0258	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—SMO—brain cancer	0.00037	0.0258	CbGpPWpGaD
Raltegravir—Dermatitis—Etoposide—brain cancer	0.00037	0.000829	CcSEcCtD
Raltegravir—Headache—Etoposide—brain cancer	0.000368	0.000824	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—OR14C36—brain cancer	0.000356	0.0248	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—OR4C12—brain cancer	0.000356	0.0248	CbGpPWpGaD
Raltegravir—Nausea—Etoposide—brain cancer	0.000349	0.000781	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—ABR—brain cancer	0.000336	0.0234	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000308	0.0214	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ABR—brain cancer	0.000305	0.0212	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DTX2—brain cancer	0.000303	0.0211	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP2C9—brain cancer	0.000298	0.0208	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000294	0.0205	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTCH2—brain cancer	0.00023	0.016	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HES5—brain cancer	0.000222	0.0155	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—STRADA—brain cancer	0.000216	0.015	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—TRPC6—brain cancer	0.000213	0.0148	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—SHH—brain cancer	0.0002	0.0139	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TRPC6—brain cancer	0.000193	0.0135	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—SMO—brain cancer	0.00019	0.0132	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PTCH1—brain cancer	0.00019	0.0132	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ABR—brain cancer	0.00018	0.0126	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GLI2—brain cancer	0.000174	0.0121	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GLI1—brain cancer	0.000164	0.0114	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.00016	0.0111	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—VAV1—brain cancer	0.000159	0.0111	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SUFU—brain cancer	0.000155	0.0108	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GFAP—brain cancer	0.00015	0.0104	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—VAV1—brain cancer	0.000145	0.0101	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HEY1—brain cancer	0.000142	0.00988	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DLL1—brain cancer	0.000139	0.00969	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000122	0.00852	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SHH—brain cancer	0.000118	0.00824	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TRPC6—brain cancer	0.000114	0.00795	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTCH1—brain cancer	0.000112	0.00781	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SMO—brain cancer	0.000112	0.00781	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PIK3CG—brain cancer	0.000101	0.00705	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PIK3CG—brain cancer	9.18e-05	0.0064	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NOTCH2—brain cancer	8.96e-05	0.00624	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VAV1—brain cancer	8.54e-05	0.00595	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HES1—brain cancer	7.35e-05	0.00512	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL2—brain cancer	7.12e-05	0.00496	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PDGFRA—brain cancer	7e-05	0.00488	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SPP1—brain cancer	6.79e-05	0.00473	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL2—brain cancer	6.46e-05	0.0045	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IRS2—brain cancer	6.14e-05	0.00428	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APC—brain cancer	5.43e-05	0.00378	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PIK3CG—brain cancer	5.43e-05	0.00378	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2C9—brain cancer	5.1e-05	0.00355	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EGFR—brain cancer	4.94e-05	0.00344	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—BSG—brain cancer	4.34e-05	0.00302	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RELA—brain cancer	4.24e-05	0.00295	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ERBB2—brain cancer	4.21e-05	0.00294	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL2—brain cancer	3.82e-05	0.00266	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—IDH1—brain cancer	3.73e-05	0.0026	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCND1—brain cancer	3.72e-05	0.00259	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CTNNB1—brain cancer	3.69e-05	0.00257	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VEGFA—brain cancer	3.24e-05	0.00226	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—STAT3—brain cancer	3.21e-05	0.00224	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MYC—brain cancer	2.99e-05	0.00208	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ENO2—brain cancer	2.95e-05	0.00205	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EGFR—brain cancer	2.92e-05	0.00203	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TP53—brain cancer	2.45e-05	0.00171	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3CG—brain cancer	1.35e-05	0.000942	CbGpPWpGaD
